Literature DB >> 32355545

LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway.

Fang Liu1,2, Xin-Chun Yang1, Mu-Lei Chen1, Zhen-Wu Zhuang2, Ying Jiang3, Jing Wang4, Yu-Jie Zhou5.   

Abstract

Arterial calcification (AC) is mainly caused by osteoblast phenotypic transition of vascular smooth muscle cells (VSMCs). Long noncoding RNA H19 (lncRNA H19) has attracted increasingly attention because of their transcriptional regulation crucial potency. We reported that lncRNA H19 expression is up-regulated after VSMCs transition. Thus, we aim to study the role of H19 and the molecular mechanisms in VSMCs transition. To determine the expression of H19 in calcified VSMCs, we induced VSMCs calcification with 10 mM β-glycerophosphate. By qPCR and Western Blot analysis, we found that the expression of lncRNA H19, Runx2 and OSX were all highly increased in calcified VSMCs compared with normal VSMCs, while the expression of VSMCs differentiation markers, SM22-α and α-SMA, were significantly decreased. SiRNA study showed that knockdown of lncRNA H19 can decrease VSMCs calcification and Runx2 expression. We further validated that lncRNA H19 promoted VSMCs calcification via the p38 MAPK and ERK1/2 signal transduction pathways. As a conclusion, the present study showed that lncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway. This finding not only reveal a novel function of lncRNA H19, but also provides a new opinion on the role of lncRNA H19 which participant in the Runx2 regulatory pathway in AC and can be a new indication for the diagnosis and treatment of AC at an early time. AJTR
Copyright © 2020.

Entities:  

Keywords:  Arterial calcification; MAPK; RUNX2; VSMCs; lncRNA H19

Year:  2020        PMID: 32355545

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  5 in total

Review 1.  Evaluating the Role of lncRNAs in the Incidence of Cardiovascular Diseases in Androgenetic Alopecia Patients.

Authors:  Masoumeh Roohaninasab; Shadnaz Fakhteh Yavari; Motahareh Babazadeh; Rozita Adldoosti Hagh; Mahboubeh Pazoki; Mehran Amrovani
Journal:  Cardiovasc Toxicol       Date:  2022-05-04       Impact factor: 3.231

2.  A long non-coding RNA H19/microRNA-138/TLR3 network is involved in high phosphorus-mediated vascular calcification and chronic kidney disease.

Authors:  Qiang Liu; Huimeng Qi; Li Yao
Journal:  Cell Cycle       Date:  2022-04-18       Impact factor: 5.173

3.  H19 Promotes Osteoblastic Transition by Acting as ceRNA of miR-140-5p in Vascular Smooth Muscle Cells.

Authors:  Feng Xu; Jia-Yu Zhong; Bei Guo; Xiao Lin; Feng Wu; Fu-Xing-Zi Li; Su-Kang Shan; Ming-Hui Zheng; Yi Wang; Qiu-Shuang Xu; Li-Min Lei; Chang-Ming Tan; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2022-02-07

Review 4.  The management of bone defect using long non-coding RNA as a potential biomarker for regulating the osteogenic differentiation process.

Authors:  Jia-Lin Liu; Yan-Shi Liu; Mei-Jie Zheng; Hui-Yu He
Journal:  Mol Biol Rep       Date:  2022-01-01       Impact factor: 2.316

5.  Melatonin Alleviates Hyperglycemia-Induced Cardiomyocyte Apoptosis via Regulation of Long Non-Coding RNA H19/miR-29c/MAPK Axis in Diabetic Cardiomyopathy.

Authors:  Haitao Tang; Hongli Zhong; Wanqing Liu; Yi Wang; Yuan Wang; Liuqing Wang; Songtao Tang; Huaqing Zhu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.